Multiplikator Forward P/S: Apyx Medical Corp (APYX)
The forward price-to-sales valuation trend highlights a steady cash inflow from the sale of disposable components for plasma systems. However, fierce competition for surgeons' attention and pressure from laser manufacturers create significant challenges. The 2.00 level is recording new values amid concerns over FDA claims and potential litigation, which are reducing the overall profitability of Apyx Medical.
Ringkesan rincian data analitis apyxmedical.com (APYX)
- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- data utang lan likuiditas:
Total Utang marang Modal Apyx Medical|APYX - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Apyx Medical Corporation|APYX - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku APYX|APYX - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Apyx Medical|Rasio cepet apyxmedical.com
- rincian asil keuangan lan kelipatan valuasi:
APYX - Penghasilan resik perusahaan|Bathi sing dikarepake Apyx Medical|APYX - Rasio kapitalisasi marang bathi resik|Prakiraan rega marang bathi Apyx Medical Corporation|APYX - Pangali PEG|Pangali EV/EBITDA APYX|APYX - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Apyx Medical|APYX - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan apyxmedical.com|APYX - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Apyx Medical
- indikator dodolan lan pendapatan:
Analisis fundamental perusahaan:APYX (Bovie Medical)
The forward P/S reflects the market value of the business relative to expected sales volume, allowing for an assessment of the premium paid for future growth rates. By analyzing the projected market cap-to-revenue ratio, an investor can gauge the market's reaction to financial reports, which is critical for Apyx Medical (APYX), as its valuation relies on the commercial success and demand for Renuvion high-precision helium plasma systems.
Karo sapa Apyx Medical saingan
Rasio rega marang prakiraan pendapatan Dexcom DXCM|PEN - Multiplikator forward rega marang pendapatan|Novanta Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Haemonetics Company|INSP: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan PRCT|CNMD (CONMED) - Multiplikator Forward P/S|Pulse Biosciences Inc (PLSE) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S INMD|Multiplikator forward rega marang pendapatan Picard Group PMI|Multiplikator Forward P/S SRDX (Surmodics, Inc.)|Multiplikator Forward P/S senseonics.com SENS|NPCE - Rasio rega marang prakiraan pendapatan|TCMD: Rasio rega marang prakiraan pendapatan|SNWV (SANUWAVE Health, Inc.) - Multiplikator forward rega marang pendapatan|Outset Medical Corp - Rega forward marang dodolan|ELMD (SmartVest) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep lensar.com LNSR|Rasio rega marang prakiraan pendapatan AVITA Medical (RCEL)|profoundmedical.com (PROF) - Prakiraan rega marang pendapatan|Baird Medical - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S EDAP TMS SA EDAP|IceCure Medical, Ltd. - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Pulmonx Corporation LUNG|telabio.com (TELA) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan CTSO (CytoSorbents Corporation)|Rasio rega marang prakiraan pendapatan Sensus Healthcare Corp|Multiplikator forward rega marang pendapatan Zynex Corp (ZYXI)|Multiplikator Forward P/S ECOR|RBOT - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Inspira Technologies IINN|ICU: Kapitalisasi marang prakiraan pendapatan|IRIX: Multiplikator forward rega marang pendapatan|Intelligent Bio Solutions - Rasio rega marang pendapatan sing dikarepake|XAIR: Multiplikator Forward P/S|profusa.com (PFSA) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan STRATA Skin Sciences Inc.|glucotrack.com - Rega mangsa ngarep marang pendapatan|Multiplikator forward rega marang pendapatan NAOV (NanoVibronix)|VERO - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Nuwellis, Inc. - Multiplikator forward rega marang pendapatan|AEMD: Kapitalisasi marang prakiraan pendapatan|ASXC: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan AVGR (Avinger Inc.)|BioSig Technologies, Inc (BSGM) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan Cutera Inc|KNW (Know Labs, Inc.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep inarimedical.com NARI|Multiplikator Forward P/S NVRO|reshapelifesciences.com - Kapitalisasi marang prakiraan pendapatan|Multiplikator Forward P/S SILK (Silk Road Medical Inc.)
